Modifications to the mcdonald mri dissemination in space criteria for use in asians with classic multiple sclerosis: The taiwanese experience

Multiple Sclerosis

Volumn 16, Issue 10, 2010, Pages 1213-1219

  Chen, Shao Yuan ^a,b   Lo, Chung Ping ^c,d   Hsu, Wen Lin ^c,d   Kao, Hung Wen ^b   Hsueh, Chun Jen ^b   Lin, Wei Chen ^e   Liu, Chia Chen ^c   Wang, Wei Yu ^c   Hsu, Chia Chun ^c,d  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^d TZU CHI UNIVERSITY   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Brain; magnetic resonance imaging; multiple sclerosis; spinal cord

Indexed keywords

GADOLINIUM;

ARTICLE; ASIAN; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PREDICTION; RADIOLOGIST; SPINAL CORD LESION; TAIWAN;

ADOLESCENT; ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN; COHORT STUDIES; CONTRAST MEDIA; DISEASE PROGRESSION; FEMALE; GADOLINIUM DTPA; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; SPINAL CORD; TAIWAN; YOUNG ADULT;

EID: 77957567019     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458510376179     Document Type: Article

References (27)

1. McDonald WI, Compston A., Edan G., Goodkin D., Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on diagnosis of multiple sclerosis. Ann Neurol 2001 ; 50: 121-127.
2. Polman CH, Reingold SC, Edan G., Filippi M., Hartung HP, Kappos L., et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005 ; 58: 840-846.
3. Chong HT, Ramli N., Lee KH, Kim BJ, Ursekar M., Dayananda K., et al. Low sensitivity of McDonald MRI criteria in the diagnosis of multiple sclerosis among Asians. Neurology Asia 2006 ; 11: 129-133.
4. Lo CP, Kao HW, Chen SY, Hsueh CJ, Lin WC, Hsu WL, et al. Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria. J Neurol Neurosurg Psychiatry 2009 ; 80: 1107-1109.
5. Barkholf F., Filippi M., Miller DH, Scheltens P., Campi A., Polman CH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 1997 ; 120: 2059-2069.
6. Tintor M., Rovira A., Martnez MJ, Rio J., Daz-Villosland P., Brieva L., et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 2000 ; 21: 702-706.
7. Swanton JK, Fernando K., Dalton CM, Miszkiel KA, Thompson AJ, Plant GT, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry 2006 ; 77: 830-833. (Pubitemid 44023177)
8. Swanton JK, Rovira A., Tintor M., Altmann DR, Barkhof F., Filippi M., et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol 2007 ; 6: 677-686.
9. Villar LM, Garca-Barragn N., Sdaba MC, Espio M., Gömez-Rial J., Martnez-San Milln J., et al. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis. J Clin Neurosci 2008 ; 266: 34-37.
10. Chausson N., Olindo S., Signat A., Smadja D. and Cabre P. Evaluation of the 2005 McDonald MRI criteria for dissemination in space in Afro-Caribbean patients with clinically isolated syndromes. Eur J Neurol 2009 ; 16: 1191-1196.
11. Chong HT, Kira J., Tsai CP, Ong B., Li PC, Kermode A., et al. Proposed modifications to the McDonald criteria for use in Asia. Mult Scler 2009 ; 15: 887-888.
12. Jacobs LD, Beck RW, Simon JH, Kinkel RP, Brownscheidle CM, Murray TJ, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 2000 ; 343: 898-904.
13. Comi G., Filippi M., Barkhof F., Durelli L., Edan G., Fernndez O., et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 2001 ; 357: 1576-1582.
14. Kappos L., Polman CH, Freedman MS, Edan G., Hartung HP, Miller DH, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology 2006 ; 67: 1242-1249.
15. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF and Weinshenker BG Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 ; 66: 1485-1489.
16. Kira JI, Kanai T., Nishimura Y., Yamakaki K., Matsushita S., Kawano Y., et al. Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996 ; 40: 569-574.
17. Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H., Bruck W., et al. Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain 2007 ; 130: 1194-1205.
18. Weinshenker BG Neuromyelitis optica is distinct from multiple sclerosis. Arch Neurol 2007 ; 64: 899-901.
19. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ and Weinshenker BG The spectrum of neuromyelitis optica. Lancet Neurol 2007 ; 6: 805-815.
20. Cabrera-G̈mez JA, Quevedo-Sotolongo L., GonzlezQuevedo A., Rodrquez-Rojas R., Quevedo-Sotolongo L., Real-Gonzlez Y., et al. Brain magnetic resonance imaging findings in relapsing neuromyelitis optica. Mult Scler 2007 ; 13: 186-192.
21. Yu CS, Zhu CZ, Li KC, Xuan Y., Qin W., Sun H., et al. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum. Radiology 2007 ; 244: 249-256.
22. Osoegawa M., Niino M., Tanaka M., Kikuchi S., Murai H., Fukazawa T., et al. Comparison of the clinical course of the opticospinal and conventional forms of multiple sclerosis in Japan. Intern Med 2005 ; 44: 934-938.
23. Pittock SJ, Lennon VA, Krecke K., Wingerchuk DM, Lucchinetti CF and Weinshenker BG Brain abnormalities in neuromyelitis optica. Arch Neurol 2006 ; 63: 390-396.
24. Graber DJ, Levy M., Kerr D. and Wade WF Neuromyelitis optica pathogenesis and aquaporin 4. J Neuroinflammation 2008 ; 5: 1-22.
25. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS and Hinson SR IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 ; 202: 473-477.
26. Misu T., Fujihara K., Kakita A., Konno H., Nakamura M., Watanabe S., et al. Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain 2007 ; 130: 1224-1234.
27. Jacobi C., Hhnel S., Martinez-Torres F., Reiger S., Jttler E., Heiland S., et al. Prospective combined brain and spinal cord MRI in clinically isolated syndromes and possible early multiple sclerosis: impact on dissemination in space and time. Eur J Neurol 2008 ; 15: 1359-1364.